Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.
You can purchase shares of Enveric Biosciences (NASDAQ:ENVB) through any online brokerage.
Other companies in Enveric Biosciences’s space includes: Biofrontera (NASDAQ:BFRI), Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), Titan Pharma (NASDAQ:TTNP) and cbdMD (AMEX:YCBD).
Enveric Biosciences has a consensus price target of $3.82.
The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.3174 last updated December 26, 2024 at 4:24 PM EST.
There are no upcoming dividends for Enveric Biosciences.
Enveric Biosciences’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for Enveric Biosciences.
Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.